ABVC BioPharma, Inc.: ABVC BioPharma Reports Third Quarter 2022 Financial and Operational Results
FREMONT, CA, Nov. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology
Source: finanznachrichten.de